Form 4: Fulgent Genetics CFO Paul Kim Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Fulgent Genetics' CFO, Paul Kim, reports the withholding of shares to cover tax obligations arising from vested restricted stock units.
Summary
- On July 26, 2024, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., reported a transaction involving the withholding of 2,738 shares of common stock to cover tax obligations.
- The shares were withheld to satisfy tax obligations related to the vesting of restricted stock units granted on November 7, 2022.
- The price per share for the transaction was $23.66.
- Following the transaction, Kim directly owns 213,300 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a standard tax-related transaction, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as officers and directors, ensuring fair market practices.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine tax-related matter for an executive.
Key Dates
| Date | Description |
|---|---|
| November 7, 2022 | Date of grant for the restricted stock units that led to the tax withholding. |
| November 9, 2022 | Original report on Form 4 filed with the U.S. Securities and Exchange Commission. |
| July 26, 2024 | Date of the stock transaction (tax withholding). |
| July 30, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.